Categories
Business

MacKenzie Scott Proclaims $4.2 Billion Extra in Charitable Giving

In her brief career as one of the world’s foremost philanthropists, MacKenzie Scott has made a name for herself for the sheer volume and speed of her donations, donating nearly $ 6 billion in her fortune this year alone.

Ms. Scott, a writer who was once married to Amazon founder and CEO Jeff Bezos, announced in a Medium post Tuesday that she’d given nearly $ 4.2 billion to 384 organizations over the past four months have. Many of the groups are focused on basic needs for millions of people during a difficult year, including food banks and meals on wheels.

“This pandemic has been a wrecking ball in the lives of Americans who have already struggled,” Ms. Scott wrote. “Economic losses and health consequences were worse for women, people of color and people living in poverty alike. Meanwhile, it has significantly increased the wealth of the billionaires. “

Mainstays like NAACP, Easterseals, Goodwill and United Way were on the list. This also applies to more than 100 separate YMCA and YWCA organizations across the country which, like many nonprofits, have lost tremendous revenue even though the demand for their services has increased.

And smaller organizations like a nonprofit affordable home lender in Minnesota and a group helping people pay off medical debts also received funding.

Ms. Scott’s post did not include the amounts paid to each organization, but it did say that the full amount pledged is prepaid and unrestricted or “no commitment” as she put it.

Morgan State University, a historically black university in Baltimore, announced it had received $ 40 million, the largest private gift in the institution’s history. Ms. Scott said the money went to groups in all 50 states, Washington and Puerto Rico.

Chuck Collins, director of the Charity Reform Initiative at the Institute for Policy Studies, said he couldn’t think of anyone who gave away more this year, at least in terms of publicly announced grants. “She’s responding to the current moment with urgency,” said Mr. Collins.

“They think of all of these tech achievements, they are the big disruptors, but it disrupts the norms surrounding billionaire philanthropy by moving fast and not creating a private foundation for their great-grandchildren to give away the money,” added Collins.

The Institute for Political Studies has pushed for legislation that will double the amount of money foundations will have to pay from 5 percent a year to 10 percent for the next three years to meet the yawning needs caused by the pandemic.

For context, the Gates Foundation, in many ways the largest and most influential nonprofit in the world, raised $ 5.1 billion in direct grants with the fortunes of both Microsoft founder Bill Gates and investor Warren E. Buffett. Dollars awarded in 2019. However, the Gates Foundation has decades of experience and more than 1,600 employees, while Ms. Scott only referred to a team of advisors to help her find good causes.

While the Gates Foundation may donate more than $ 5.9 billion through its Covid-19 response, the number shows how quickly Ms. Scott has risen to become the number one donor worldwide.

In July, Ms. Scott announced that she had donated $ 1.7 billion to historically black colleges and universities, as well as groups promoting women’s rights, LGBTQ equality and the fight against climate change, among others. Howard University said at the time it had received $ 40 million, a donation it described as “transformative”.

When Ms. Scott and Mr. Bezos were divorced last year, Ms. Scott received 4 percent of Amazon’s outstanding shares, or 19.7 million shares. They were valued at around $ 38.3 billion at the time. Those stocks would be valued at approximately $ 62 billion today after a pandemic-triggered surge in Amazon stocks. It’s not clear how many stocks she sold.

Categories
Politics

Senate passes $740 billion protection invoice as Trump veto menace looms

An F-35B Lightning II fighter aircraft with Marine Medium Tiltrotor Squadron (VMM) 265 (Reinforced), 31st Marine Expeditionary Unit (MEU), prepares for takeoff from the flight deck of the amphibious assault ship USS America (LHA 6) prior to a strike exercise inflatable maritime target.

Lance Cpl. Joshua Brittenham | US Marine Corps | FlickrCC

WASHINGTON – The Senate passed a colossal defense policy bill on Friday despite multiple threats from President Donald Trump to veto the measure.

At least 75 members of the Republican-led Senate voted for the massive annual defense bill of $ 740 billion, a number larger than the two-thirds majority it would take to defeat Trump’s promised veto.

With the weight of the House and Senate behind the National Defense Authorization Act (NDAA), the bill hits Trump’s desk with overwhelming support from Congress.

The NDAA, which is usually passed with strong support from both parties and veto-proof majorities, approves spending totaling 740 billion US dollars and outlines Pentagon policies.

Earlier this month, Trump threatened to veto the must-pass defense law if lawmakers fail to remove legal protections for social media companies.

Trump is calling for the repeal of a federal law known as Section 230 of the Communications Decency Act, which protects tech giants like Facebook and Twitter from legal liability for what is posted on their platforms.

Last week, Trump described the provision as a “liability protection gift” for “Big Tech” and called for it to be “terminated entirely”, otherwise he would not use this year’s NDAA.

The president also said the move posed a serious threat to US national security and electoral integrity, but did not provide any further explanation. Trump has also said that Twitter, his favorite social media platform, wrongly censored him.

The President’s problem with Section 230 came to light this summer after Twitter added warnings to several of its tweets that alleged mail-in polls were fraudulent. Trump has still not allowed Democrat Joe Biden to hold the US presidential election.

US President Donald Trump speaks after the swearing-in ceremony of James Mattis as Secretary of Defense on January 27, 2017 at the Pentagon in Washington, DC.

Almond Ngan | AFP | Getty Images

This year’s legislation includes a 3% pay increase for US troops, a plan to rename military facilities with the names of Confederate leaders, and a number of other provisions.

The NDAA, in its current form, does not contain any action related to Section 230.

This is not the first time the president has targeted the NDAA. Earlier this year, Trump said he would veto the measure if it included language for changing U.S. military facilities named after Confederate generals.

Categories
Business

AstraZeneca to Purchase Alexion for $39 Billion

LONDON – Drug maker AstraZeneca on Saturday agreed to buy Alexion, a biopharmaceutical company, for $ 39 billion in cash and stock as corporate giants return to making large acquisitions even during the pandemic.

The deal comes as AstraZeneca is in the final stages of testing a Covid-19 vaccine it is developing with Oxford University, one of the best-known candidates – but which also had questions about its effectiveness.

With the deal for Alexion, the largest of a healthcare company this year, AstraZeneca will enhance its offering in rare diseases such as blood disorders. It is because the company’s boards of directors continued to regain confidence after the hatches were closed in the early stages of the pandemic.

Since the stock markets have risen sharply and debt financing continues to be cheap due to central bank policy, companies have resumed their pursuit of growth and scalability – also through acquisitions.

Under the terms of the contract, AstraZeneca will pay $ 60 in cash and 2.1243 of its US depository receipts for each Alexion share. That’s $ 175 per share, a premium of nearly 45 percent over Alexion’s closing price on Friday.

Headquartered in Cambridge, England, AstraZeneca has focused on cancer treatments for the past several years after losing patent protection for its best-selling drugs, such as the Crestor cholesterol treatment. In July, the company agreed to pay up to $ 6 billion to partner with Japanese drug maker Daiichi Sankyo for a possible treatment for lung and breast cancer.

But AstraZeneca has been best known in the last few months for its work in another area: Covid-19 vaccines, where it works with researchers from Oxford.

The two announced in late November that their coronavirus vaccine appears to be 90 percent effective. Unlike some other leading vaccine candidates, including those from Pfizer and Moderna, the AstraZeneca range can be manufactured in large quantities quickly, would cost only a few dollars per dose, and is easy to store for long periods of time.

However, scientists and industry experts asked questions almost immediately after AstraZeneca admitted a material error in the vaccine dosing of some study participants. The question now arises whether the effectiveness of the vaccine will be maintained with additional tests.

The deal for Alexion will help AstraZeneca expand into another sector: immunology, where treatments can be very lucrative for their manufacturers. Boston-based Alexion is known for its focus on fighting rare diseases: top medications include Soliris and Ultomiris, which treat blood disorders.

Each costs several hundred thousand dollars a year. This underpins AstraZeneca’s expectation that the deal will result in double-digit sales increases and a higher dividend payout by 2025.

“Alexion has established itself as a leader in complement biology bringing life-changing benefits to rare disease patients,” said Pascal Soriot, managing director of AstraZeneca, in a statement.

The company has been put under pressure in recent years by Elliott Management, the $ 41 billion investment firm owned by financier Paul E. Singer. The hedge fund has repeatedly criticized Alexion for its business strategy, including multi-billion dollar corporate acquisitions that have proven disappointing. (The stock fell sharply on the day Alexion announced the acquisition of Portola Pharmaceuticals in May, indicating investor dissatisfaction with the deal.)

Shortly thereafter, Elliott asked the drug maker to sell itself. A spokeswoman for the hedge fund declined to comment on Saturday.

Alexion’s shareholders are expected to own approximately 15 percent of the combined company upon completion of the transaction, which is expected by next September, subject to regulatory approvals and investors in both companies.